Ryan Tunis
Stock Analyst at Cantor Fitzgerald
(2.47)
# 2,394
Out of 5,138 analysts
39
Total ratings
88.24%
Success rate
5.57%
Average return
Main Sectors:
Stocks Rated by Ryan Tunis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WTW Willis Towers Watson | Maintains: Neutral | $365 → $345 | $329.41 | +4.73% | 1 | Jan 14, 2026 | |
| WRB W. R. Berkley | Maintains: Overweight | $78 → $76 | $67.88 | +11.96% | 1 | Jan 14, 2026 | |
| TRV The Travelers Companies | Maintains: Overweight | $308 → $316 | $269.42 | +17.29% | 4 | Jan 14, 2026 | |
| TRUP Trupanion | Maintains: Neutral | $50 → $42 | $32.44 | +29.47% | 1 | Jan 14, 2026 | |
| RYAN Ryan Specialty Holdings | Maintains: Neutral | $63 → $52 | $51.48 | +1.01% | 1 | Jan 14, 2026 | |
| RNR RenaissanceRe Holdings | Maintains: Neutral | $252 → $282 | $269.92 | +4.48% | 1 | Jan 14, 2026 | |
| LMND Lemonade | Maintains: Overweight | $85 → $92 | $79.41 | +15.85% | 1 | Jan 14, 2026 | |
| KNSL Kinsale Capital Group | Maintains: Neutral | $470 → $422 | $398.84 | +5.81% | 1 | Jan 14, 2026 | |
| HIG The Hartford Insurance Group | Maintains: Overweight | $152 → $160 | $129.59 | +23.47% | 6 | Jan 14, 2026 | |
| GSHD Goosehead Insurance | Maintains: Overweight | $125 → $111 | $71.57 | +55.09% | 1 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $348 → $344 | $318.81 | +7.90% | 1 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $309 | $300.77 | +2.74% | 1 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $450 → $393 | $343.86 | +14.29% | 1 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $344 → $282 | $258.52 | +9.08% | 3 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $77 | $72.93 | +5.58% | 5 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $93 → $97 | $90.65 | +7.00% | 1 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $202.37 | -58.00% | 6 | Oct 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $114 | $192.28 | -40.71% | 3 | Aug 7, 2018 |
Willis Towers Watson
Jan 14, 2026
Maintains: Neutral
Price Target: $365 → $345
Current: $329.41
Upside: +4.73%
W. R. Berkley
Jan 14, 2026
Maintains: Overweight
Price Target: $78 → $76
Current: $67.88
Upside: +11.96%
The Travelers Companies
Jan 14, 2026
Maintains: Overweight
Price Target: $308 → $316
Current: $269.42
Upside: +17.29%
Trupanion
Jan 14, 2026
Maintains: Neutral
Price Target: $50 → $42
Current: $32.44
Upside: +29.47%
Ryan Specialty Holdings
Jan 14, 2026
Maintains: Neutral
Price Target: $63 → $52
Current: $51.48
Upside: +1.01%
RenaissanceRe Holdings
Jan 14, 2026
Maintains: Neutral
Price Target: $252 → $282
Current: $269.92
Upside: +4.48%
Lemonade
Jan 14, 2026
Maintains: Overweight
Price Target: $85 → $92
Current: $79.41
Upside: +15.85%
Kinsale Capital Group
Jan 14, 2026
Maintains: Neutral
Price Target: $470 → $422
Current: $398.84
Upside: +5.81%
The Hartford Insurance Group
Jan 14, 2026
Maintains: Overweight
Price Target: $152 → $160
Current: $129.59
Upside: +23.47%
Goosehead Insurance
Jan 14, 2026
Maintains: Overweight
Price Target: $125 → $111
Current: $71.57
Upside: +55.09%
Jan 14, 2026
Maintains: Neutral
Price Target: $348 → $344
Current: $318.81
Upside: +7.90%
Jan 14, 2026
Maintains: Neutral
Price Target: $300 → $309
Current: $300.77
Upside: +2.74%
Jan 14, 2026
Maintains: Overweight
Price Target: $450 → $393
Current: $343.86
Upside: +14.29%
Jan 14, 2026
Downgrades: Neutral
Price Target: $344 → $282
Current: $258.52
Upside: +9.08%
Jan 14, 2026
Maintains: Neutral
Price Target: $80 → $77
Current: $72.93
Upside: +5.58%
Jan 14, 2026
Maintains: Neutral
Price Target: $93 → $97
Current: $90.65
Upside: +7.00%
Oct 18, 2019
Maintains: Outperform
Price Target: $90 → $85
Current: $202.37
Upside: -58.00%
Aug 7, 2018
Initiates: Outperform
Price Target: $114
Current: $192.28
Upside: -40.71%